Fig.5. Tradeoff between fatal bleeding and coronary thrombosis in the acute phase.

In the acute phase, all patients (groups 0–5) had a higher risk of MB than of any MI (upper row). ARC-HBR (group 1–5) patients have a balanced risk between fatal MI and FB, whereas non-ARC-HBR (group 0) patients have a higher risk of fatal MI than of FB (bottom row). Abbreviations: MI, myocardial infarction; MB, major bleeding; FB, fatal bleeding.